Experts commented that there is no treatment method that can admit the effectiveness of the treatment of novel coronavirus infection (Corona 19) other than'remdesivir' and'dexamethasone'.

It is recommended that antiviral treatment is unnecessary for young and chronically ill patients with COVID-19, and that antiviral treatment should be performed mainly for elderly and chronically ill patients.

Amid the spread of Corona 19 across the country, the Central Clinical Committee for New Infectious Diseases held a press conference today (25th) at the National Medical Center and released the'Corona 19 Treatment Recommendation'.

According to the recommendations, the optimal treatment strategy for patients with COVID-19 has not yet been determined.

The clinical committee said, "There is no treatment method that can be admitted to the effect other than the early symptom improvement effect of remdesivir and the mortality reduction effect of dexamethasone when the data published or published to date are synthesized."

The clinical committee advised that "therapies other than those in clinical trials with permission should not be used for the purpose of treating COVID-19."

The AIDS treatment'Kaletra' and the malaria treatment'Chloroquine', which were used in the early days of Corona 19 in Korea, were not recommended as treatments.